Sugi Predict

Sugi Predict / Targets / PTMS

PTMS

Parathymosin · P20962 · PTMS on Sugi Atlas →

0 patent compounds predicted against PTMS, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PTMS by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Vitamin D and Carboxy PTH Fragments in Coronary Calcification PHASE4WITHDRAWN
Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate PHASE4COMPLETED
TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis PHASE3COMPLETED
Comparison Study of PTHrP and PTH to Treat Osteoporosis PHASE2COMPLETED
PTHrP(1-36) IV Dose Escalation Study PHASE1WITHDRAWN
The Effect of Chymosin on the Intestinal Absorption of Calcium PHASE1COMPLETED
Carbamylation in Renal Disease-modulation With Amino Acid Therapy EARLY_PHASE1COMPLETED
7 Day Continuous Parathyroid Hormone IV Infusion EARLY_PHASE1COMPLETED
Integrated Proteomic HPLC-ESI-MS Analysis of Salivary Peptides of Preterm Newborns: a Pilot Study nanCOMPLETED
Uncovering the Mechanism of Pain Relief by Peripheral Transcutaneous Magnetic Stimulation nanRECRUITING
Proteomic Analysis of Newly Restored Single Implants nanCOMPLETED
The Long-term Effect of Daily Jarlsberg Cheese Intake in Patient With Osteopenia nanCOMPLETED
Effects of Interval Training Effects on Cardiac Fibrosis nanCOMPLETED
Effects of Naturally Silicon-Rich Water on Bone Metabolism in Women nanCOMPLETED
Gait and Balance Parameters Before and After Parathyroidectomy in Patients With Primary Hyperparathyroidism nanCOMPLETED
The Effect of Aerobic Exercise on Bone Turnover Markers in Postmenopausal Patients nanCOMPLETED
Study of the Regulation of Parathyroid Hormone Secretion in Pseudohypoparathyroidism nanCOMPLETED
Assessment of Protein Modification in Chronic Kidney Disease - Selected Clinical and Biochemical Aspects nanCOMPLETED
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING
Studying Phosphorus Metabolism nanCOMPLETED
The Bone-parathyroid Crosstalk in Primary Hyperparathyroidism nanUNKNOWN
Parathyroid Hormone (PTH) Homeostasis in Bartter Syndrome nanUNKNOWN
The Relation Between Thyroid , Parathyroid Hormones and eGFR in CKD Patients in Assiut nanUNKNOWN
Planetary Habitat Simulation: Bone Metabolism Studies nanCOMPLETED
The Oswestry Metabolic BONE Cohort nanNOT_YET_RECRUITING
Volumetrics and Proteomics in Shunted Normal Pressure Hydrocephalus nanUNKNOWN
Ischemic Preconditioning - Perspectives of Use Vivio/in Vitro Studies nanENROLLING_BY_INVITATION
Effect of Dialysis-specific Therapeutic Diet on Biochemical Parameters in Dialysis Patients nanACTIVE_NOT_RECRUITING
New Transporting Solution in Parathyroid Allotransplantation nanUNKNOWN
The Role of Amylin in Bone Metabolism nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a PTMS binder may also engage these)

ProteinNameSimilarity
P08814 — 1.000 P08814 →
P04550 — 1.000 P04550 →
Q9D0J8 — 0.999 Q9D0J8 →
P26350 — 0.986 P26350 →
Q5U274 — 0.981 Q5U274 →
P06302 — 0.981 P06302 →
P01252 — 0.981 P01252 →
PTMA Prothymosin alpha 0.981 landscape →
Q90ZK2 — 0.979 Q90ZK2 →
Q5R790 — 0.978 Q5R790 →
Q6NV32 — 0.977 Q6NV32 →
Q68F55 — 0.976 Q68F55 →
A5PLC8 — 0.973 A5PLC8 →
Q9VQF7 — 0.967 Q9VQF7 →
Q10020 — 0.956 Q10020 →
P02316 — 0.951 P02316 →
P05204 — 0.950 P05204 →
P05114 — 0.950 P05114 →
Q6PD99 — 0.950 Q6PD99 →
P17691 — 0.949 P17691 →
A3LXX5 — 0.947 A3LXX5 →
P02313 — 0.947 P02313 →
P06837 — 0.947 P06837 →
P12274 — 0.946 P12274 →
P12902 — 0.946 P12902 →
P80272 — 0.946 P80272 →
Q5R715 — 0.946 Q5R715 →
P02314 — 0.946 P02314 →
P16527 — 0.946 P16527 →
Q5ZIR5 — 0.945 Q5ZIR5 →